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INTRODUCTION 
__  A~-
During the  1950s there was felt to be  a  need to have  Materials Testing 
Reactors  (MTRs)  in  Europe.  By  their contribution to studies  on safety, these 
reactors proved to be an indispensable tool in the pursuit of all programmes for 
the development of nuclear power. 
The  reduction, slowing down or phasing  out of these  programmes had 
important consequences  on the operation  of these reactors which are also used 
for other purposes  -such  as  the  production of radioisotopes for medical  use 
(diagnostic or therapeutic)- which have become a more significant factor in the 
exploitation of MTRs, without providing in themselves an optimal work load. 
The decision to close  down the two oldest reactors,  DIDO  and  PLUTO  at 
Harwell, was taken in 1988 for essentially economic reasons. 
Faced with that situation and with requests from certain Member States, the 
Commission conferred a technical study in  1988 on Dr. J. Williams, ex-Director of 
the Harwell research establishment.  The conclusions arrived at in the study were 
communicated in February 1989 to the Council and the Euratom Scientific and 
Technical Committee (STC). 
It soon appeared necessary to extend and deepen this technical study by an 
analysis taking into account all the pertinent scientific, technical and economic 
elements and with a longer forward projection.  , 
Such  an  analysis  was  conferred on  the  Chairman  of the  STC,  Dr.  Jules 
Horowitz, but to carry through so ambitious a mandate required a relatively long 
time scale in particular because of international uncertainty fuel supply and fuel 
cycle especially on research reactors. 
Nevertheless, to get clear ideas on questions dealing with their exploitation, 
the Commission decided to establish a Coordination Group set up with operators 
ofthe four Materials Testing Reactors still operating in the Community, in parallel 
with the completion of Mr. Horowitz's report as quickly as possible. 
Research Ministers took note of this decision at the Council of 29 April 1992 
when adopting the Multiannual  Research  Programmes of the Joint Research 
Centre. - 2. 
I. 
TEST REACTORS 
IN THE CO:MMUNlTY - 3. 
·  Test reactors were the starting point and the basis of the peaceful utilization 
of nuclear energy and are older than the technical employment of this energy 
source.  The classical  uses of research  reactors worldwide extend over many and 
varied fields of application:  examination of reactor-geometries, studies of the 
behaviour of materials and  nuclear  fuels,  isotope  production  by  neutron 
irradiation, application of techniques using neutron diffusion in the field of the 
science of matter and of biology and the education and training of physicists and 
reactor technicians. 
The concept of a MTR  reactor in  general is  a compact core with enriched 
uranium with a  U235  assay  equal to or greater than  19,75  %  enabling  high 
neutron flux to be generated.  In  Europe, the most important reactors are either 
of the "open swimming pool" type or "closed-tank" reactors but there are also 
many other types of research reactor.  Thermal power of  test reactors ranges from 
some hundreds of kilowatts up to somewhat more than 100 MW. 
Finally, an  important point is  that the irradiation process  itself is  but the 
main element in an experiment which also requires preparation beforehand and 
examination after irradiation.  The proportion of the cost of irradiation in the 
total  cost  of an  experiment is  very  variable and  in certain  cases  that of the 
additional equipment needed to perform an irradiation can be much greater. 
Historically, test reactors in the Community fall into two categories: the first 
and  oldest, were  general  purpose  machines intended to  satisfy  numerous 
different requirements; the rest were designed to respond to more specific needs 
and in general were more powerful.  This distinction is  less  clear today.  Under 
economic pressure, the more specialized  reactors are often used  for work of a 
very  general  nature.  However,  the  most difficult projects  need  specific 
equipment, and thus the most costly experiments, may be associated with one 
rather than another reactor. 
These considerations somewhat modulate the notion of overcapacity. There 
is  little effective duplication  of means  between  test  reactors  in  terms of 
irradiation experiments are currently undertaken or might be undertaken in the 
future.  A  possible excess  availability of neutrons in  test reactors does not 
necessarily mean that there is an excess capacity available for using the reactors 
for particular irradiation experiments.  In fact such capabilities cannot be easily or 
cheaply moved from one reactor to another. 
Table 1 shows the salient points of MTRs.  The two reactors DR3 at Risa and 
FRJ2 at Julich are shown for information. TABLE 1 : Testing Reactors in the Community 
Reactor  Located at  Exploiter  Started up  Nominal  Moderator  Fuel  Main experiments carried 
Power  (1)  out or characteristics 
Loops using a high fast  flux. 
BR2  Mol (B)  CEN/SCK  1961  80  Be/H20  HEU  Instrumented capsules. 
Possibility 
ofupto125  . 
Measurements of mechanical 
HFR  Petten (NI)  JRC (2)  1961  .  45  H20  HEU  properties.  BNCT Installation. 
lnstrumentedcapsules. 
SmaiL loops, instr.umented 
SILOE  Grenoble (F)  CEA  196,3  :35  H20  HEUILEU  capsules.  On-line fission product 
laboratory. 
Big loops.  Instrumented  capsules. 
OSIRIS  Saclay (F)  CEA  1966  70  H20  LEU  Easy accessibility to the core.  Large 
experimental volume 
Instrumented capsules. 
DR3  RIS0 (Dk)  RIS0  1960  10  D20  LEU 
FRJ2  Julich (D)  KFA  1962  23  D20  HEU  (Reactor Stopped) 
HEU (High Enriched Uranium) (up to 98 %) in U235 
LEU  (Low Enriched Uranium) (19.5 %) in U235 
-------
(1)  Current situation 
(2)  The high flux reactor in Petten is entrusted to the Commission of  the European Communities by Council Decision (supplementary programme), but its technical operation is 
assured by ECN (Energie Centrum Nederlands). - 5. 
·  Requested  by the Commission  and ·focused on the utilization of MTRs  by 
Community programmes and the future requirements of the latter, Dr. Williams' 
1989 study clearly showed that the mix of capabilities, available in the Community 
for carrying out irradiations, cannot be matched elsewhere in the western world. 
If this situation can be maintained the Community's potential future needs would 
be covered.  · 
Reciprocally, the viability of the Materials Testing Reactors is determined by 
national  and  industrial  programmes  as  those  coming  from  Community 
programmes only contribute in a minor way. 
Finally, regarding the potential availability of MTRs in the Community over 
the coming 10 years, Dr. Williams drew the Commission's attention to the fragility 
of the situation and to the fact that a reorganization of the system  might be 
imposed  by failure of the reactors one by  one rather than  as  a  result of any 
balanced consideration of  the overall situation. - 6. 
II~ 
THE COORDINATION GROUP 
ON TEST REACTORS - 7. 
In  the letter of 24  April  1992  addressed  to Permanent Representatives of 
each of the Member States concerned with the exploitation of a Materials Testing 
Reactor, the Commission announced the creation of a Coordination Group, under 
the guidance of the Director General of the Joint Research  Centre, comprising 
operators and with the aim of promoting greater consistency  in the operation 
and use of these reactors and the examination of possible means of intervention 
for the  preservation  of these  materials testing  reactors  in  the  Community, 
particularly in those sectors where they are essential.  The  Council of Ministers 
(Research)  which  met on  29  April  1992, took  note  in  this  respect  of the 
Commission's  Declaration joined to the Decision  on  the  HFR  Supplementary 
Programme. One Delegation stressed what was to be expected from the exercise; 
in particular underlining problems linked to the recent attitude of the American 
Administration on the fuel cycle  of these  reactors,  and with  reference to the 
worrying situation in the Eastern  countries, together with the essential  role of 
these reactors with regard to nuclear safety. 
I.  The Exploitation of Testing Reactors: Economic Aspects. 
In  his technical study, Dr. Williams had noted: "In these circumstances it is to be 
expected  that specialist  skills  needed  to  undertake  particular types of 
experiments, associated  with the particular irradiation capabilities of each 
reactor,  have grown up on  each  reactor site.  It follows that these specialist 
capabilities are not easily  transferred  from site  to site, if in  fact they  are 
transferable at all." (annex 4, paragraph 3). 
Each  operator (CEN/Mol,  CEA,  lAM  of the  JRC)  of testing  reactors  in  the 
Community contributed to the establishment of a global view by presenting the 
means  by  which the various exploitation costs  are  charged;  the Coordination 
Group conferred the examination of such  questions on a working group which 
has been asked to prepare a report. 
The conclusion of the Williams' report was rapidly recognized by members of the 
Coordination Group, where it became dear that each operator calculated prices 
for irradiation services  on the basis  of criteria  intimately connected with the 
specificity of each  reactor which rendered the comparison of prices extremely 
difficult.  The Group decided to focus its attention on cost evaluation and in the 
way different parameters are  included, with the  ob~ective of findinl Jossible 
distortions. Table 2 follows the conclusions of  this wor  . It presents the  olowing 
arguments: 
concerning the depreciation indicated in Table 2,  the exploitation of the 
High  Flux  Reactor  (HFR)  at -Petten  is  the subject of a  supplementary 
programme by a Council decision every four years.  This decision must follow 
closely the budgetary rules of  the Community: inscription of  all expenditures 
in the budget in the year of their commitment. 
operations for refurbishement vary  according  to the reactor concerned. 
Such an operation should be undertaken on the reactor BR2 on the occasion 
of the replacement of the beryllium matrix.  Other reactors have been, to a 
greater or lesser extent, subjected to such operations.  The HFR  reactor was 
completely refurbished in  1984, for OSIRIS  and SILOE,  refurbishement is  a 
permanent feature of operation. 
the question of the provision made for the reprocessing of fuel and storage 
of waste is intimately connected to fuel supply which is examined later. -8 .. 
TABLE 2: COMPARATIVE COST STRUCTURES 
BR2  HFR  OSIRIS I SILOE 
Foreseen in the 
DEPRECIATION:  budget of the 
(*)  year of financial  yes since 1991 
Refurbishment  commitment 
Reactor  no  no  no 
Buildings  no  no  no 
Foreseen in the 
Projects  yes  budget of the  yes 
year of financial 
commitment 
Foreseen in the 
New investments  yes(*)  budget of the  yes 
year of financial 
commitment 
PROVISIONS : 
Reprocessing  yes  (*)  (*) 
Storage  yes  yes  yes 
Decommissioning reactors  no  no  yes 
Decommissioning of new  yes  yes  yes 
installations  -
OVERHEADS: 
Reactors  yes  yes  yes 
Organization  no  yes  yes 
CONTINGENCIES :  no  no  no 
(*)  cf. see specific annex for this reactor -9. 
Conclusions ofthe Group: 
Based on Table 2 and complementary information, the Coordination Group did 
not find any significant distortion in the calculation of exploitation costs of any 
reactor. 
II.  Financiallnstruments 
The Coordination Group has  examined  all  possibilities offered by the financial 
instruments available in  the Community for construction, operation or in-depth 
refurbishment of  Testing Reactors. 
The  Council  Decision  No  77/270/Euratom  of 29  March  1977  (JO  l88,  6.4.77) 
stipulates in Article  1 that the purpose  of Euratom  loans  is  the financing  of 
investment projects relating to the industrial production of electricity in nuclear 
power plants.  With reference to article 2c of the Euratom Treaty, the 4th recital 
recalls that the Community  must  "facilitate  investment  and  ensure  the 
establishment of the basic installations necessary for the development of nuclear 
energy in the Community". 
As  has already been  underlined, testing reactors are an  indispensable element, 
notably in their contribution to the safety of nuclear installations.  Therefore, 
they would  eventually conform to criteria  set  out by the  Council  for the 
attribution of Euratom loans. 
The Commission will continue to examine, in close  liaison with operators, 
application modalities of the Council Decision to these reactors, as well as  the 
possibility of intervention by the European Investment Bank. 
Ill.  Materials Testing Reactor Safety 
The safety of MTRs and more widely that of research reactors has been a topic of 
international  cooperation  for years.  More than  320  research  reactors are 
operational worldwide in 54 countries: more than twice the number of countries 
with power reactors.  A number of these are "developing countries" and benefit 
from the assistance of  the International Atomic Energy Agency (IAEA). 
Very  early, the IAEA  attached great importance to all  safety  aspects  of these 
reactors:  the establishment of criteria and standards for safety;  assistance with 
research and setting up a structure for the exchange of technical information and 
of experts. 
Thus, the safety of research  reactors is based  on I.A.EA publications which are the 
result of a large international consensus  covering  all  aspects  {radioprotection, 
waste management, and safety itself). 
"Safety Fundamentals" constitute a presentation of safety concepts, safety 
objectives and fundamental principles or requirements; 
"Safety Standards"  establish  the essential  requirements which  must be 
satisfied  to guarantee safety.  These  requirements are  formulated  in 
regulations accompanied by recommendations; - 10. 
"Safety Guides"  contain  recommendations to fulfil  requirements or 
principles set out in the above-mentioned documents; they are written in an 
obligatory format because  they are  consequential  requirements tied to 
those  in a safety standard or they recommend  ways to implement these 
requirements; 
"Safety Practices" give practical examples and detailed methods on how to 
implement certain safety requirements. 
Other safety-related documents which may contain additional topics and which 
are  not predominantly written to ensure  safety  are  collected  in  Reports or 
Technical Documents (TEC DOC). 
The first two types of document treat design and operation of reactors.  They 
cover  matters concerning  safety authorities, the site,  quality assurance,  etc. 
Safety  Guides  deal  with safety assessment,  utilization  and  modifications, 
commissioning  of reactors,  emergency  planning and decommissioning.  Safety 
Practices  address topics such  as  instrumentation  and  control, radioprotection 
services, maintenance and surveillance, operational limits and conditions, as well 
as operating instructions. 
Table 3 shows the hierarchical organization of  these publications. 
At the same time, since 1972 the IAEA has carried out missions concerned with the 
safety of research  reactors (INSARR:  Integrated Safety Assessment  of Research 
Reactors) which places high importance on design, on operational aspects as well 
as on radiological protection.  For the last two years, particular interest has been 
focused on research reactors in Eastern European countries and in 1990 an INSARR 
was organized in Russia. 
Members of the Coordination Group underlined that at a European  level, the 
European  Atomic Energy Society  (which  includes research  establishments in 
Community Member States)  created  in  1988,  a  Research  Reactors  Operators 
Grouping (RROG)  comprising  representatives of Germany,  Bel~ium, Denmark, 
Finland, France, Norway, the Netherlands, Portugal, the United Ktngdom, Sweden 
and Switzerland, together with the IAEA and the Commission of the European 
Communities. The Grouping in particular decided to reinforce cooperation on the 
safety of  research reactors. 
In conclusion, the Coordination Group expressed particular satisfaction about the 
quality of international collaboration which exists in the fundamental field of 
nuclear safety.  It  considered that increased support should be given to the work 
of the IAEA and of the RROG  and to this end a close  coordination should be 
established between operators to prepare their contributions together.  The 
Commission agreed to provide the framework for this collaboration. IAEA RESEARCH REACTOR SAFETY PUBUCATIONS (Schematic) 
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VI.  Fuel cycle of  testing reactors 
1.- Fuel evolution. 
In  the  beginning  of the  50s,  the  American  authorities  encouraged  the 
development of peaceful utilization of nuclear energy through the programme 
"Atoms for Peace"  launched by President Eisenhower in  December 1953.  This 
. programme led to the transfer of until then secret information, from the United 
States to Europe and the first test reactors were built, in the United Kingdom and 
then in the rest of  Western Europe. 
At the beginning, U235 assay in the fuel was generally of the order of 20%.  At the 
end of the 50s, it  was increased to 93% to allow higher neutron fluxes. 
The United States have always been and officially still  are the only supplier of 
highly enriched uranium (HEU).  Until 1974, this HEU  could be leased from the 
former Commission  of American  Atomic Energy  (AEC).  Operators of testing 
reactors had to pay only rather low leasing charges in the order of 5%  per year on 
the basis of the consumption of  the uranium, including burn-up and losses. 
Around 1974, the American commercial policy changed and operators of testing 
reactors had to purchase the material.  However, the procurement of American 
HEU was relatively easy and was not encumbered by administrative obstacles. The 
particularly attractive prices offered by the DOE and the conditions proposed (see 
paragraph 3)  eliminated competition.  But in  1977,  President Carter declared 
himself to be concerned about "the wide spread of weapons-usable material" in 
testing reactors. 
He  took the initiative to start an  International Fuel  Cycle  Evaluation  (INFCE). 
Working Group No  8 of this new action was charged with investigating how to 
avoid the utilization of HEU and to promote fuels having a reduced Uns assay. 
As a result of this working group, it was decided that the ideal U235  assay  was 
19.75%  ±  0.2%.  In order to maintain fuel element geometry, an increase of fuel 
density was necessary.  Development of such  a high density fuel  was the subject 
of the RERTR (Reducing Enrichment in Research and Test Reactors) programme of 
the Department of Energy (DOE) and of an  international cooperation involving 
many organizations and enterprises of the Community.  In September 1990, the 
annual meeting decided that the RERTR  programme had achieved its objectives 
because the majority of research and testing reactors could be converted to low 
enriched fuel  (LEU)  to below 20%.  Consequently, the development of high 
density fuel for certain  high performance reactors,  has  ceased:  these  reactors 
continue to use highly enriched fuel. 
2.- The supply of highly enriched uranium and the fabrication of fuel 
The  preceding  paragraph showed that the United States  has  established  and 
developed a  monopoly on the supply of enriched  uranium used  for peaceful 
purposed with U235 assays from 10 to 98%. - 13. 
The supply of uranium by the Department of Energy (DOE)  is carried out under a 
contract which generally specified that the material would be  delivered as  the 
hexafluoride (UF6),  but made provision for conversion to the metal as  an  extra 
service available on request.  This was temporarily suspended from mid 1989 to 
mid 1990 and the Frenchfirm COGEMA met needs during the period. 
The export of enriched uranium of American origin is  covered  by the "Nuclear 
Non-Proliferation  Act"  (NNPA)  of 1978  and  by  the  "Atomic Energy Act"  as 
amended.  Consequently, export licences can only be given on a case by case basis  · 
and not as a general authorization.  To obtain such a licence for highly enriched 
uranium requires the establishment of a detailed inventory of materials present 
on the  reactor site  and  the justification  of new  requests together with  a 
declaration of use.  The transport of HEU to Europe has considerably decreased in 
the last few years and the cancellation of  certain means of transport has increased 
its difficulty.  Nevertheless, there still exist enough stocks  in  the Community to 
cover the needs, at least in the short term.  The fabrication of fuel for MTRs (and 
for research  reactors)  is  carried  out in  the Community  by  the Atomic Energy 
Authority (AEA) at Dounreay and above all, by the French company CERCA which, 
since its amalgamation with the relevant department of  the German firm NUKEM, 
has become the largest producer of research reactor fuel in the world. 
Other fabricators exist,  such  as  the Danish  national  laboratory at Ris0,  which 
produces elements for use in its own reactor DR3, however, the principal factory 
outside the Community is that of Babcock and Wilcox in Lynchburg in the United 
States. 
3.- Reprocessing and Waste Disposal. 
Until recently, the United States were not only the supplier of highly enriched 
uranium to Europe but also carried on the reprocessing of spent fuel in two plants 
belonging to the DOE:  Idaho National  Engineering  Laboratory  (INEL)  and 
Savannah River Site in South Carolina, also used for irradiated fuel from military 
reactors.  The  DOE  took charge of the waste and the plutonium, the  reactor 
operator receiving a credit in highly enriched uranium against his following order. 
In fact, the plutonium was not separated but treated with the waste.  This policy 
began  with the  "Atoms for Peace"  programme and  was  pursued  up to  31 
December 1988. 
Effectively, at that date, the DOE  had to elaborate a study on the environmental 
impact of its  policy ("Environmental  Assessment").  The  long  environmental 
administrative  procedure  necessary  for the  exercise  already  introduced 
considerable  uncertainty in the pursuit of the  DOE's  policy,  also  criticized  on 
economic grounds.  The decision taken in February 1992 to stop the reprocessing 
of spent fuel from the U.S.  Navy as soon as possible, has only served to reinforce 
the uncertainty. 
Questions concerning the tail-end of the MTR  fuel  cycle  are  being posed  ever 
more sharply not only. for the Community but for those  operating  research 
reactors throughout the world, except for American ones for which the DOE's 
policy is still valid. 
Solutions which might be envisaged  in the Community framework are already 
being  examined  in  Member States  possessing  the  necessary  technology; 
essentially France and the United Kingdom. - 14. 
Questions relating to the tail-end of the fuel cycle may have consequences on the 
supply of HEU.  The constraints weighing on American material and the expected 
intentions of the DOE  regarding  prices  may  render that source  of supply  less 
attractive and encourage the search for other potential suppliers.  The number of 
possibilities offered is limited because only the Community (France and the United 
Kingdom) and the Russian  Federation are in a position to offer highly enriched 
uranium. 
4.- Special Fuels. 
As  a reminder, certain special .fuels, at the end of the cycle  have to be treated 
individually.  Their original characteristics make it impossible to reprocess them 
with other research reactor fuels,  Reprocessing possibilities should be examined 
as should other options such as treatment to prepare for permanent storage. 
5.- Conclusions. 
Questions  relatin~ to the fuel cycle  of materials testing reactors are, among 
others, one item m  the mandate conferred on the Chairman  of the  Euratom 
Scientific and Technical  Committee (STC)  Mr. Horowitz, and his study should 
allow the examination of technically and economically possible ways.  These will 
be the subject of a special attention by the Commission which will not fail to 
make a report to the Council when the conclusions of the Scientific and Technical 
Committee become available. 
Nevertheless,  the  Coordination  Group  wished to  underline the  present 
incoherence of American policy.  It considered that all possible solutions should 
be examined. 
V.  The special case of medical applications. 
As  has  already been  said,  the utilization of testing  reactors for medical 
purposes for the production of radioisotopes,  necessary  for the diagnosis and 
therapy of certain illnesses (notably cancer)  has  been financially marginal until 
now.  The  necessity  of maintaining  a  production  in  Europe  of these 
radioelements, whose future is tightly connected to testing reactors, had led the 
Commission to finance an in-depth study on this question and to consult with the 
principal organizations and industries concerned. 
1.- A discipline particularly important for public health. 
Medical use of radioactive isotopes is today part of normal medical practice and 
permits highly specialized examination or therapy to be carried out.  Although it 
involves specialist techniques, the number of patients concerned is large. 
For diagnosis, there exist about 3,500 gamma cameras in Western Europe, located 
in  1,800 specialized centres (generally hospitals).  In total, more than  5 million 
examinations of this type are carried out each year on about 4.5 million patients. - 15. 
In  the area  of therapy, current applications,  apart from  cobalt-therapy, are 
strongly targetted:  classical  radiotherapy  concerns  approximately  300,000 
patients  in  Western  Europe.  As  for metabolic radiotherapy  (for thyroid, 
rheumatism of the joints, polyglobulins, etc.} some 30,000 to 50,000 patients per 
year are treated. 
During recent years,  the rate of development of nuclear medicine has  reached 
approximately 6-7%  per year, expressed  in the volume of products used and the 
the sale of gamma cameras. 
2.- Radioactive isotopes use in medicine. 
Rays  emitted by  radioactive elements find  medical applications in  in  vivo 
diagnosis,  as  measuring  signals  and  in  therapy,  as  a  means of very  local 
destruction. Reminder: very small quantities of iodine 125 are also used as tracers 
in in vitro diagnosis. 
Choice of  isotopes: a difficult compromise 
The choice of elements used depends on several factors: 
the type of rays  emitted (y  rays  are  used  for diagnosis and  y  and p in 
therapy); 
the  period of the radioactive  isotope (very  short to limit undesirable 
secondary effects in the patient but sufficiently long to permit production 
and transport, the best compromise being, in most cases,  in the order of 3 
days); 
eventual affinity with an organ or a tissue type, tropism for a function or a 
particular metabolism; 
energy adapted to application: level compatible with sensitivity range of 
gamma  camera  in  diagnosis,  total  energy  delivered  which  permits 
destruction of  tumors or cysts in therapy; 
chemical properties of isotopes (ability of association with vectors). 
These  different parameters are  shown  in  Figure  1 and  have allowed the 
identification of more than 20 radioactive isotopes of medical importance. 
Double origin of  isotopes 
Radioactive isotopes use  in medicine are produced in two types of installation: 
nuclear research  reactors (mainly MTRs)  and  cyclotrons,  with the exception of 
cobalt 60,  an  element of long lifetime, which  is  mostly produced  in thermal 
nuclear power plants, when irradiation time is of the order of 3 years.  However, 
except in  exceptionally rare  circumstances,  this means of production  is  not an 
alternative: isotopes in use can  in general only be produced in a single type of 
installation.  . 
The  principle vocation of research  reactors is  to test materials used  in  nuclear 
power plants.  However, the most powerful of them (essentially MTRs)  can  also 
produce the isotopes needed in medical applications.  These are extracted from a 
target irradiated by the reactor's neutron flux. RESPECT OF CONSTRAINTS 
(Medical purpose, Protection of patient, Isotope logistics, Required radiation intensity)· 
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This target is made either from enriched uranium from which fission products are 
extracted (molybdenum 99, xenon 133, iodine 131, etc.) or from stable isotopes, 
sometimes enriched, close  to the one which it is  wished to obtain (cobalt 60, 
iridium 192, rhenium 186, etc.).  Cyclotrons on the other hand, are installations 
specially conceived for medical use._ The principle production is different in that 
cyclotrons generate fluxes of electrically charged particles. 
Radioactive isotopes produced by research reactors cover: 
a  great majority of diagnostic applications.  Those most often  used  are 
technecium 99m {obtained from the decay of molybdenum 99)  and iodine 
131, but at the same time there are 9ther isotopes for particular applications 
(iron 59, chromium 51, xenon 133, etc.); 
all isotopes used .in  therapy at present,  notably, iodine 131,  iridium  192, 
rhenium 186, ytrium 90 etc.; 
products coming from cyclotron irradiations are only applied in diagnosis 
and are principally thallium 201, iodine 131  and gallium 67.  Table 4 and 
Figure 2 illustrate this situation. 
3.  Problems with the production of radioactive isotopes 
A situation which could be~ome  critical. 
European  needs  in  medical  radioactive  isotopes supplied  by  R &  D  reactors 
represent an added value resulting from irradiation,,pf between 5 and 6 Mioecu 
in 1992.  This figure probably does not represent the real cost because operators 
of  these reactors consider medical irradiations as being a marginal business which 
is not taken into account when planning future activities.  Currently, irradiation 
costs represent some 30% of the price of an isotope that can  be used directly but 
may drop to under 10%  if intermediate equipment is  necessary  (a  technecium 
generator for example).  There is no doubt that the part consisting of irradiation 
services making up the price of medical products will rapidly grow, which in turn 
will result in an increase in prices themselves. 
Because  of the slowing down of civil  nuclear  progeammes, the medium-term 
future of four European  reactors  (BR2,  Belgium;  0SIRIS,  SILOE,  France;  HFR, 
Netherlands) most concerned with medical applications may be put in doubt. Any 
reduction in the number of these  reactors  and thus the capacity available for 
medical applications could lead to a serious rupture in the supply of radioactive 
isotopes.  In  general, these  radioactive  isotopes cannot be stored  and  reserve 
stocks  with  producers  only  represent  at the  most,  one  or two  days  of 
consumption; continuous production is therefore necessary.  This problem is even 
more critical since the isotopes concerned have a short lifetime. 
In  case  of a shortfall  in  capacity  in  Europe, the  European  doctor would find 
himself dependent on  Canadian  production,  which  already covers  certain 
European needs.  Apart from dependence on what is in fact a monopoly, security 
of supply cannot depend on a unique and distant producer (lifetime too short for 
certain elements, risk  of limitation or prohibition of international transport of 
highly radioactive  substances,  risk  of inte-rruption of supply  by  unforeseen 
occurrences,  risk of possible  breakdown of installations).  this situation would 
prove critical for the greater part of the isotopes in use at present. 1'WENTY ISOTOPES ARE FREQUENTLY USED IN  MEDICINE 
CYCLOTRON 
ORIGINEOF 
ISOTOPE 
NUCLEAR 
R&D 
REACTOR  I 
l MEDICAL PURPOSE  I 
DIAGNOSIS 
Isotope 
- Gallium 67 
- Indium 111 
- lode123 
- Thallium 201 
Period 
3.2 days 
2.8 days 
13.3 hours 
3.0 days 
Product from generator : 
Krypton 81  13 seconds 
Isoto~  Period 
Chrome 51  27.7days 
Iron 59  44.5 days 
lode 131  8.0 days 
lode 125  59.9 days 
- Xenon 133  5.2 days 
Products from generators : 
Indium 113  1.6 hours 
- Technetium 99  6.2 hours 
THERAPY. 
Isotope 
- Cesium 137 * 
- Cobalt 60 * 
- Erbium 169 
- lode131 
- Iridium 192 * 
- Gold 198 
- Phosphore 32 
- Rhenium 186 
- Strontium 85 
- Yttrium 90 
Period 
30.0 years 
5.3 years 
9.5 days 
8.0days 
74.0 days 
2.7days 
14.3 days 
3.7 days 
64.8 days 
2.7 days 
(*) The patient is only temporarily exposed to the source of  radiation classical radiotherapy and transcutaneous radiotherapy 
TABLE  4-
,...._ 
~ 
.... 
I ALL THERAPY AND MOST DIAGNOSTICS (Number treated) USE 
NUCLEAR R&D REACTOR-PRODUCED ISOTOPES 
CYCLOTRON 
NUCLEAR 
R&D 
REACTOR 
DIAGNOSIS 
- Less than 
25 o/o 
Greater 
than·7s% 
MEDICAL  PURPOSE 
THERAPY 
100 o/o  . 
FIG. 2-
ESTIMATES 
.:1'. 
,· 
\ 
u 
I 
\ 
I 
I -20. 
In conclusion, the Coordination Group states that in view of the importance for 
public health of medicine using isotopes produced by nuclear research reactors 
and mainly MTRs, the Community cannot allow serious ruptures to their supply. 
Only a "local'" production can serve to cushion any risk of this type.  Taking into 
account the necessary delays and financial consequences tied to any long-term 
solution, the problem, solutions and the resulting consequences have to be 
resolved immediately. 
VI.  Towards a reinforced concertation on the use of MTRs 
The Coordination Group made a detailed examination of all aspects relevant 
to the irradiation services  market offered by  materials testing  reactors  in  the 
Community.  Participants unanimously underlined their concerns regarding the 
development of the international  market.  The  possible  emergence into this 
market of reactors sited in Eastern countries and meeting only uncertainly criteria 
established in the Community for the operation of MTRs could lead to problems 
later.  On the other hand, it is apparent that existing contacts between operators 
are insufficient to be certain of being able to meet the exigencies of the market 
on a permanent basis. 
The operators present recognized the interest of profound exchanges they 
had in the various meetings of the Coordination Group and wished to continue 
these in an  appropriate framework, in particular with the aim of following the 
examination of items partially tackled in the limited framework of  the Group. 
The Coordination Group has thus decided on the creation of an operators" 
club for MTRs  to which other organizations could  be associated  (notably the 
reactor at Ris" in Denmark and eventually the R2 in Sweden); the organization of 
the club should be conferred on the Commission. 
In addition, the Group returned to an in-depth examination of the situation 
of medical arplications where participants considered that the importance and 
sensitivity o  the subject should lead to the creation of an  European Economic 
Interest Grouping  focussing  on  this  very  precise  activity  in  MTRs.  The 
Commission  is  asked  to examine in detail all  the  implications of this.  The 
Commission agrees to give every assistance needed in the constitution of such a 
grouping. - 21. 
III. 
CONCLUSIONS 
.  ' -22. 
The work of the Coordination  Group on  Materials Testing  Reactors  in  the 
Community set up in  conformity with the wishes of the Council of Ministers 
(Research) of 29 April1992 reached the following conclusions: 
1) 
2) 
3) 
4) 
with respect to economic aspects  relating to the exploitation of the 
reactors, based on information provided by operators, the Group was 
unable to find  any  significant distortion  in  the  calculations  of 
operating costs for any reactor. 
concerning the setting up of financial instruments, more particularly 
Euratom  Loans,  the Commission  will continue to examine,  in  close 
liaison with operators, modalities of application to these  reactors of 
the Council  Decision  No  77/720/Euratom together with  intervention 
possibilities by the European Investment Bank. 
with  reference to the  safety  of materials  testin~ reactors,  the 
Coordination Group expressed particular satisfaction a out the quality 
of international collaboration already in existence.  It considered that 
increased support should be brought to the work of the IAEA and to 
the Research Reactors Operators' Grouping and that for that purpose a 
close concertation between operators should be established to prepare 
their contributions together.  The Commission agreed to furnish the 
framework for this collaboration. 
questions relating to the fuel cycle  of materials testing reactors are, 
among others, one item in the mandate conferred on the chairman of 
the Euratom Scientific and Technical  Committee (STC)  Mr. Horowitz, 
and  his  study should  allow the  examination  of technically  and 
economically possible ways.  These  will  be  the subject of a  special 
attention by the Commission which will not fail report to the Council 
when the conclusions of the Scientific and  Technical  Committee 
become available. 
Nevertheless, the Coordination Group wished to underline the present 
incoherence of American  policy.  It considered  that all  possible 
solutions should be examined. 
5)  The Coordination Group's attention was drawn to medical applications 
and it considers that in view of the importance to public health, of the 
use, in medicine, of isotopes produced by nuclear research reactors and 
mainly MTRs,  the Community cannot allow serious ruptures to their 
supply.  Only a "local" production can serve to cushion any risk of this 
type.  Taking  into account the  necessary  delays  and  financial 
consequences tied to any long-term solution, the problem, solutions 
and the resulting consequences have to be resolved immediately. -23. 
6}  The  Coordination  Group  has  thus decided  on  the creation  of an 
operators'  club for MTRs  to which  other organizations should  be 
·associated (notably the reactor at Rise in Denmark and eventually the 
R2 in Sweden}. The organization of the club has been conferred on the 
Commission.  · 
In  addition, the Group returned to an  in-depth  examination of the 
situation of medical applications where participants considered that 
the  importance and  sensitivity  of the subject should  lead to the 
creation of an European Economic Interest Grouping focussing on this 
very precise activity in MTRs.  The Commission  is asked to examine in 
detail all the implications of this.  The Commission agrees to give every 
assistance needed in the constitution of  such a grouping. -24. 
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JA/gp/92.0537 
Re  Additional  c0111118nts  on  th• cost structure of HFR  Petten 
The  technical  subgroup  on  pricing  policy  of  the  co-ordination  group  on 
material  testing  reactors  has  arrived  at  a  comparative  table  on  costing 
structures for  BR2,  HFR,  OSIRIS,  SILOE. 
The  following  additional  comments  are given to the related lines of the table. 
DEPRECIATION 
Refurbishment 
Investments  into refurbishment  and  purchase  of  new  equipment  required  for 
'  ' 
reactor operation,  as  well  as  major  refurbishments  and  maintenance  of the 
building  complex  are  included  in  the  costs;  they  are  budg~ted in year  of 
commitment. 
Reactor/buildings 
Depreciation of investments  into the HFR  complex  (reactor installation and 
buildings)  is not  included  in  the operation  costs. 
Product  related/projects 
All  irivestnients ·into  ancillary  equipment  for executing  the  exploitation 
programme,  as  well  as  investments  into  dedicated  facilities  is  included 
into the  operation  costs  and  budg~ted in  year of commitment. 
''  .. · '•'  ~ 
New  investments 
Addressed  under  refurbishment. 
'-iis1ting address:  \Nesterduin~·~eg 3  - 1755 LE  Petten.  The Neth~rlancls 
'  '  ' PROVISION 
Reprocessing 
- 26-
Until  end  of  1988  the  full  costs  of  the  back  end  of  the  fuel  cycle  were 
included  in  the  HFR  irradiation  tariffs,  i.e.  the  costs  of  reprocessing 
were  fully taken  into account.  These  costs were  more  than  balanced  by  the 
credits for unburnt  uranium  in  the  spent  fuel.  Since  the beginning  of 1989 
the  return  shipments  of  spent  fuel  to  the  USA  were  suspended  and  no 
expenditures  for  reprocessing  were  made.  At  the  same  time  the  full  price 
for  fresh  uranium  had  to  be  paid  without  compensation  for uranium  credits 
resulting  from  the  return  of  spent  fuel.  Last  month  the  US-DOE  announced 
that  the  DOE  reprocess 1  ng  p  1  ants  will  be  phased  out.  As  a  consequence 
reprocessing  in  the  USA  can  no  longer  be  regarded  as  an  option.  In  view  of 
this  new  situation  the  Commission  decided  to  include  a  provision  for 
reprocessing  in  the  HFR  operation  costs  as  per  June  1992. 
Storage 
All  expenditures  for  temporary  on-site storage of spent  fuel  elements  are 
included  in  the  operation  costs. 
Dismantling  reactors 
No  provision  is made  for dismantling  of the  HFR. 
Dismantling  new  installation 
Ohmantl ing  of  experimental  equipment  and  related  waste  disposal  is 
included  in  the  project costs. 
OVERHEADS 
Reactor/organization 
All  reactor  operation  related  overheads  as  well  as  exploitation  related 
overheads,  including administration and  infrastructure and JRC headquarters 
are  included  in  the  HFR"'operat1on/util1zation  cost. 
·. - ----·--·-- ' ---
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COMMISSARIAT A l'~NERGIE ATOMIQUE 
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9.07.92 
COST OF AN EXPERIMENT 
1  -COST OFAN EXPERIMENT 
The cost of an experiment in a reactor comprises : 
A/ Studies and realizations related  to the rig and measuring and control systems 
and their associated informatics. 
8/ Experiment engineering  :  preparation, surveillance,  analysis of the  results 
accompanied by calculation of nuclear characteristics, the dosimetry campaign 
possibly  using  a  mock-up,  surveillance  of parameters with  adjustments to 
conditions mainly at the start of the cycle, data treatment, the measurement of 
neutron detectors, preparation of the report ... 
C/  Neutron costs.  The  latter are only treated in  terms of the operation of the 
reactor concerned, in all cases the following are also taken into account: 
surveillance of experiments by shift operators, the analysis of alarms with 
or without consequences on the operation of the reactor, 
manipulations of the rig concerned for its transfer to and from hot cells 
and/or to and  from various  positions in the pool  for non-destructive 
examination, 
recuperation of samples and sending them to specialized laboratories, 
safety analysis of each experiment, 
providing the interface with the Safety Authorities, the operator having 
responsibility for the safety of the reactor and its experimental load. 
The service  under points A and  8  havirig  been  defined, the group of charges 
included  in the neutron costs  will  be  shown, these  being the  result of the 
weighting between the operational budget and the experimental load. 
2  -BUDGET 
The operational budget for the reactos OSIRIS and SILOE comprises: 
_LABOUR  CHARGES 
These consists of the overall labour charges to which is added : 
Technical  and  administrative  support  from  the  Department  of 
Experimental Reactors, - 2<;J-
Logistic charges for the Nuclear Reactors Directorate, 
CEA headquarters charges, 
Early retirement charges to which certain  reactor operating staff have a 
right (manipulation hall, hot cells, .... ) 
.OPERATION 
This consists  of all  orders connected  wHh  reactor operation and  includes 
renewal  of items and  replaceable  components,  not forgetting  contracts 
between  supporting  units  of  the  Centres  (effluent  treatment, 
decontamination, staff transport,  medical  surveillance,  heating, ambulance 
and fire services,  entry control ... ) and  maintenance contracts  signed  with 
enterprises  . 
. BASIC NUCLEAR INSTALLATION TAX 
In France, every basic nuclear installation (I.N.B.) is subject to taxation by the 
Ministry of Industry.  The  tax  is  to cover operational  costs  of the Safety 
Authorities. 
The item comprises : 
supply and conversion costs, 
fuel element fabrication and inspection costs, 
transport costs of irradiated e.lements, 
reprocessing or storage costs in dedicated facilities such  as PEGASE  (in the 
pool) and CASCAD (dry storage) at CEN, CADARACHE . 
. ELECTRICITY AND WATER 
This item differs considerably between OSIRIS  and SILOE  because the latter 
uses the river DRAC  as  a source of cooling water whereas with the cooling 
towers used by OSIRIS water consumption is very high  . 
. WASTE 
The item consists of a part of the services ·rendered by the Centres in treating 
liquid effluents,  precondition·ing  the  residues  and conditioning the solid 
waste.  To that is added transport within each Centre as well as extra-mural 
transport for storage managed and charged for by ANORA. . HEALTH PHYSICS 
Staff for the surveillance and measurement of ionising radiation who are 
present at reactors  is  not managed  by the Reactor  Department but by  a 
support unit at each centre.  Services are thus billed annully pro-rata with the 
staff deployed, in agreement with the Safety Authorities  . 
. REFURBISHING 
Refurbishing carried out before 1991  did not appear in bills for irradiations. 
Since  that time, depreciation for expenditures of this nature is  included 
(change of the control system presently in course at OSIRIS and the installation 
of  new heat exchangesin "SILOE") . 
. DECOMMISSIONING 
In the same way, since  1991, the year in which agreements between the CEA 
and  its  partners  EDF  and  FRAMATOME  were  signed,  a  provision  for 
decommissioning the installations has  been  included  when  establishing 
neutron costs. 
3  -REMARKS 
Dosimetry and neutron calculations associated with reactor operation are 
included within the relevant neutron cost envelope.  Services related to an 
experiment itself appear under point B above, in the first paragraph. 
Depreciation of investments connected with the construction of the two 
reactors (in 1960 and 1966) is not  taken into account. - 3.c-
ADDITIONAL  COICJCIH'fS  OM  THB  COJCPMATIVB  'l'A.BLll 
ON  COS'l'  S'l'RUC'l'UJ\8  01'  BR2: 
DIPRICIATIOR 
ANNEX  3- · 
•  ~efurbiehmenta  the  BR2  coat model  doe•  not  incorporate any 
depreciation  for  the  refurbiahment of  BR2,  since it ha•  not  yet 
taJcen  place  . 
Normally,  in the eveftt that refu:biahment will  L.a·k•  plac:•, 
thele c:o1t1  ean  be  taken  into account  for prieinq purpt,.,.,.. 
•  R••c:tor/buildint•  •  clepreciatd.on  c:harc;••  related to paat. 
inve1tment1  in buildin;a or ganeral reactor equipment are not 
included. 
* Product related  I  p~ojeeta  a the only exception waa·  made  tor 
specific product related  invea~enta that we:e  made  in the 
past.  In  the  AIU  model,  the  impact on  total c:oat  ia rather 
~mall. 
*  New  inveatment••  new  expected inveatmenta  until  replac•ment  of 
tha Se•matr.tx  (within  l  to  4  year•  )  are taken into account  but 
are kept at mJ.nfmmn.  It 11  expected however  that real 
invAatm~ntl in the next  cominq  y•ar• will be hiqher th4n  thQse 
rnnaidered  for the model. 
rt il waa  e•rtain that IR2  would  be oporation4l alter a 
S•-mat~i.x  raplac•"'""~; t.ht•• additional  inv  ..  at.m4nt  ( -.stimatc:d 
at:  aome  20  MaEP  per  yea~:)  ahoulcl  bo  taken into account !or 
~~ieinq purpo•ea. ·'' 
->1-
Storage  :  in the waste costs there is a  small portion that 
is related to  temporary storage of  waste  and  a  provision 
for final burrial.  Th~se amounts  are paid on  an  annual 
basis·to the official institute NIRAS  in Belgium. 
Costs  for  the storage of  fuel  elements,  however,  are yet 
not  included.in the cost model. 
Dismantling  BR2  reactor  :  no  provision is made  for 
dismantling the  BR2  reactor. 
Dismantling  new  installation  :  for  the  new  installations 
which will operate until the replacement of  the current 
Be-matrix,  provisions are made  for dismantling  and  waste 
management;  they are spread over the remaining  life-time 
of  the current matrix. 
OVERHEADS 
BR2  Reactor  :  only specific  BR2  related overhead is taken 
into account  in the cost model. 
These costs  are  : 
- porters  BR2  building 
- BR2  radiation control 
- cleaning  BR2  buildings 
- maintenance 
- accounting fissile materials 
- emergency plan 
- quality control on  BR2  products 
- dosimetry 
- nuclear insurance 
- CPU  time 
- management  BR2. 
Organisation  :  general  SCK  overhead costs are at present not 
taken  into account in the  BR2  cost model. 
These costs are  : 
cost for medical  service 
- cafetaria,  library 
- marketing and  communication 
- general and analytical accounting 
- costs of  central workshops  (technical services) 
- data processing department 
- cleaning of  buildings other than  BR2 
- general administration  (telephone,  fax,  car rental) 
infrastructure works 
- purchasing department 
- personnel administration 
- general security and safety other than  BR2  related. 
In order to recover the full exploitation costs  a  portion of 
these general  overhead costs  should  be attributed to the  BR2 
products. 